LifeSci Venture Partners
29
77M
23
4.14
1
0.21
6
- Stages of investment
- Areas of investment
Summary
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline Cala Health, Orasis Pharmaceuticals, Biolinq Among the most successful fund investment fields, there are Clinical Trials, Life Science.
We also calculated 3 valuable employees in our database.
Opposing the other organizations, this LifeSci Venture Partners works on 15 percentage points less the average amount of lead investments. The top amount of exits for fund were in 2019. The fund is generally included in 2-6 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2019.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the LifeSci Venture Partners, startups are often financed by Roche Venture Fund, RiverVest, Novo Ventures. The meaningful sponsors for the fund in investment in the same round are Rock Springs Capital, Redmile Group, Boxer Capital. In the next rounds fund is usually obtained by JDRF T1D Fund, Aphelion Capital.
Investments analytics
Analytics
- Total investments
- 29
- Lead investments
- 1
- Exits
- 6
- Rounds per year
- 4.14
- Follow on index
- 0.21
- Investments by industry
- Biotechnology (24)
- Health Care (13)
- Therapeutics (9)
- Medical (8)
- Pharmaceutical (8) Show 14 more
- Investments by region
-
- United States (27)
- Israel (2)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 108M
- Group Appearance index
- 1.00
- Avg. company exit year
- 2
- Avg. multiplicator
- 2.85
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Clade Therapeutics | 03 Nov 2021 | Biotechnology | Early Stage Venture | 87M | United States, Massachusetts, Cambridge |
| Savage Medical | 07 May 2024 | Health Care, Manufacturing, Medical Device | Early Stage Venture | 30M | United States, California, Belmont |
| Snackable News | 10 Jan 2015 | Advertising, Content Creators, Content Discovery, Content Marketing | Seed | 50K | Jordan, Amman |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.